Comparative Effectiveness of Ustekinumab and Anti-TNF Agent as First-Line Biological Therapy in Luminal Crohn's Disease: A Retrospective Study From 2 Referral Centers.
暂无分享,去创建一个
A. Bitton | F. Zerbib | W. Afif | T. Bessissow | P. Riviere | D. Laharie | F. Poullenot | P. Lakatos | M. Hupé | Alexander Ni | G. Pellet | C. Kanters | N. Aboulhamid | P. Rivière